U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H24O7S
Molecular Weight 408.465
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TESAGLITAZAR

SMILES

CCO[C@@H](CC1=CC=C(OCCC2=CC=C(OS(C)(=O)=O)C=C2)C=C1)C(O)=O

InChI

InChIKey=CXGTZJYQWSUFET-IBGZPJMESA-N
InChI=1S/C20H24O7S/c1-3-25-19(20(21)22)14-16-6-8-17(9-7-16)26-13-12-15-4-10-18(11-5-15)27-28(2,23)24/h4-11,19H,3,12-14H2,1-2H3,(H,21,22)/t19-/m0/s1

HIDE SMILES / InChI

Molecular Formula C20H24O7S
Molecular Weight 408.465
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 16:24:21 UTC 2023
Edited
by admin
on Fri Dec 15 16:24:21 UTC 2023
Record UNII
6734037O3L
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TESAGLITAZAR
INN   JAN   MI   USAN   WHO-DD  
INN   USAN  
Official Name English
GALIDA
Brand Name English
AR-H-039242
Code English
TESAGLITAZAR [USAN]
Common Name English
BENZENEPROPANOIC ACID,.ALPHA.-ETHOXY-4-(2-(4-((METHYLSULFONYL)OXY)PHENYL)ETHOXY) ,(.ALPHA.S)-
Systematic Name English
Tesaglitazar [WHO-DD]
Common Name English
TESAGLITAZAR [MI]
Common Name English
TESAGLITAZAR [JAN]
Common Name English
AZ-242
Code English
AR-H039242XX
Code English
(2S)-2-Ethoxy-3-[4-[2-[4-[(methylsulfonyl)oxy]phenyl]ethoxy]phenyl]propanoic acid
Systematic Name English
tesaglitazar [INN]
Common Name English
BR-44608
Code English
(S)-2-ETHOXY-3-(4-(2-(4-METHYLSULFONYLOXYPHENYL)ETHOXY)PHENYL)PROPANOIC ACID
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C98233
Created by admin on Fri Dec 15 16:24:21 UTC 2023 , Edited by admin on Fri Dec 15 16:24:21 UTC 2023
Code System Code Type Description
INN
8092
Created by admin on Fri Dec 15 16:24:21 UTC 2023 , Edited by admin on Fri Dec 15 16:24:21 UTC 2023
PRIMARY
MERCK INDEX
m1262
Created by admin on Fri Dec 15 16:24:21 UTC 2023 , Edited by admin on Fri Dec 15 16:24:21 UTC 2023
PRIMARY Merck Index
EPA CompTox
DTXSID4048773
Created by admin on Fri Dec 15 16:24:21 UTC 2023 , Edited by admin on Fri Dec 15 16:24:21 UTC 2023
PRIMARY
NCI_THESAURUS
C75985
Created by admin on Fri Dec 15 16:24:21 UTC 2023 , Edited by admin on Fri Dec 15 16:24:21 UTC 2023
PRIMARY
FDA UNII
6734037O3L
Created by admin on Fri Dec 15 16:24:21 UTC 2023 , Edited by admin on Fri Dec 15 16:24:21 UTC 2023
PRIMARY
MESH
C501413
Created by admin on Fri Dec 15 16:24:21 UTC 2023 , Edited by admin on Fri Dec 15 16:24:21 UTC 2023
PRIMARY
WIKIPEDIA
TESAGLITAZAR
Created by admin on Fri Dec 15 16:24:21 UTC 2023 , Edited by admin on Fri Dec 15 16:24:21 UTC 2023
PRIMARY
CAS
251565-85-2
Created by admin on Fri Dec 15 16:24:21 UTC 2023 , Edited by admin on Fri Dec 15 16:24:21 UTC 2023
PRIMARY
DRUG BANK
DB06536
Created by admin on Fri Dec 15 16:24:21 UTC 2023 , Edited by admin on Fri Dec 15 16:24:21 UTC 2023
PRIMARY
PUBCHEM
208901
Created by admin on Fri Dec 15 16:24:21 UTC 2023 , Edited by admin on Fri Dec 15 16:24:21 UTC 2023
PRIMARY
USAN
QQ-51
Created by admin on Fri Dec 15 16:24:21 UTC 2023 , Edited by admin on Fri Dec 15 16:24:21 UTC 2023
PRIMARY
SMS_ID
100000089231
Created by admin on Fri Dec 15 16:24:21 UTC 2023 , Edited by admin on Fri Dec 15 16:24:21 UTC 2023
PRIMARY
EVMPD
SUB25217
Created by admin on Fri Dec 15 16:24:21 UTC 2023 , Edited by admin on Fri Dec 15 16:24:21 UTC 2023
PRIMARY
ChEMBL
CHEMBL282686
Created by admin on Fri Dec 15 16:24:21 UTC 2023 , Edited by admin on Fri Dec 15 16:24:21 UTC 2023
PRIMARY
Related Record Type Details
EXCRETED UNCHANGED
URINE
BINDER->LIGAND
BINDING
TARGET -> AGONIST
Tesaglitazar is a novel dual-acting peroxisome proliferator-activated receptor alpha and gamma agonist.
TARGET -> AGONIST
Tesaglitazar is a novel dual-acting peroxisome proliferator-activated receptor alpha and gamma agonist.
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
Volume of Distribution PHARMACOKINETIC INTRAVENOUS ADMINISTRATION

AT STEADY-STATE

Tmax PHARMACOKINETIC ORAL ADMINISTRATION